Companies: 10,795·Total market cap: $144.5T
Sagimet Biosciences Inc.

Sagimet Biosciences Inc.

SGMTNASDAQHealthcare● Active
$6.70
+$0.17(+2.58%)
Market Cap$218252425
P/E Ratio—
52W High$11.41
52W Low$4.5
SEC Filings

Sagimet Biosciences Inc. (SGMT) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001400118 · SGMT · NASDAQ · as of Jun 10, 2026

Filing snapshot

235
Total Filings
8-K
Latest Form
2026-06-03
Most Recent
2023
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001400118 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-11
Fiscal Year End
Mar 11, 2026
Accession No.
0001104659-26-026140
Primary Document
sgmt-20251231x10k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001400118 · Accession 0001104659-26-026140

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-12
View 10-Q on SEC
8-KCurrent Report
FORM 8-K
2026-06-03Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
FORM 8-K
2026-06-03
View
3Initial Statement of Beneficial Ownership
OWNERSHIP DOCUMENT
2026-05-14
View
8-KCurrent Report
FORM 8-K
2026-05-12
View
10-QQuarterly Report
10-Q
2026-05-12
View
8-KCurrent Report
FORM 8-K
2026-04-28
View
424B5424B5
424B5
2026-04-28
View
8-KCurrent Report
FORM 8-K
2026-04-27
View
8-KCurrent Report
FORM 8-K
2026-04-27
View
ARSARS
ARS
2026-04-21
View
DEF 14AProxy Statement
DEF 14A
2026-04-21
View
8-KCurrent Report
FORM 8-K
2026-04-21
View
S-8Employee Stock Plan Registration
FORM S-8
2026-03-11
View
S-8Employee Stock Plan Registration
FORM S-8
2026-03-11
View
8-KCurrent Report
FORM 8-K
2026-03-11
View
10-KAnnual Report
10-K
2026-03-11
View
Showing 1–15 of 164 filingsForm 4 / 144 hidden· 235 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001400118  |  Exchange: NASDAQ · Healthcare

Sagimet Biosciences Inc. (NASDAQ: SGMT) has submitted 235 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2023. As a Healthcare sector company with CIK 0001400118, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Sagimet Biosciences Inc.'s most comprehensive regulatory disclosure. The most recent Sagimet Biosciences Inc. 10-K was filed on 2026-03-11 for fiscal year ending 2026. Historical SGMT 10-K annual reports are available from 2007 through 2026.

Investors researching Sagimet Biosciences Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-10
Related Companies SEC Filings — Healthcare
ACHV SEC Filings →ASMB SEC Filings →AVIR SEC Filings →TRDA SEC Filings →HUMA SEC Filings →ZURA SEC Filings →FHTX SEC Filings →VYGR SEC Filings →
→ SGMT Financials→ SGMT Earnings→ SGMT Insider Trades

Frequently Asked Questions

SGMT SEC Filings · 8 questions

Sagimet Biosciences Inc. (SGMT) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 235 filings and access original documents at no cost. Sagimet Biosciences Inc.'s CIK is 0001400118.

SGMT SEC filingsSagimet Biosciences Inc. SEC documentsfind SGMT 10-K